Patent 11839471 was granted and assigned to Covidien on December, 2023 by the United States Patent and Trademark Office.
In some examples, a system is configured to determine, using a neural network algorithm of a cerebral autoregulation model, a cerebral autoregulation status of the patient based at least in part on a blood pressure of the patient over a period of time and regional cerebral oxygen saturation of the patient over the period of time.